SCHEMBL20102453

SCHEMBL20102453

CCOc1ccc2c(c1F)-c1c-2cc(C2CC2)c(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.36
FGFR2 P21802 1/20 0.35
FPR2 P25090 3/20 0.33
SSTR3 P32745 1/20 0.31
SSTR5 P35346 1/20 0.31
KCNH2 Q12809 1/20 0.31
HTR2A P28223 2/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
HTR2C P28335 2/20 0.31
HTR2B P41595 2/20 0.31
PTGDR2 Q9Y5Y4 2/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20117597 0.95 ALDH1A1 (0.34) KDM1AFGFR2FPR2ALDH1A1
SCHEMBL20102450 0.95 PTGDR2 (0.37) KDM1AFGFR2HTR2AALDH1A1LMNA
SCHEMBL20102451 0.95 ALOX5AP (0.36) KDM1AFGFR2HTR2APTGDR2
SCHEMBL20102455 0.93 PTGDR2 (0.39) KDM1AALDH1A1LMNAHPGDTSHR
SCHEMBL20111583 0.93 PTGDR2 (0.39) KDM1AALDH1A1LMNAHPGDTSHR
SCHEMBL20102420 0.91 KDM1A (0.31) KDM1AFGFR2
SCHEMBL20102452 0.90 KDM1A (0.34) KDM1AFGFR2FPR2HTR2AALDH1A1
SCHEMBL20102431 0.89 MAPT (0.34) SSTR5PTGS1PTGS2ALDH1A1HPGD
SCHEMBL20102421 0.89 HPGD (0.32) KDM1AHPGDMAPT
SCHEMBL20111344 0.89 PTGDR2 (0.32) KDM1AALDH1A1LMNAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S KDM1A 1263/4885FGFR2 168/4885FPR2 869/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S KDM1A 1263/4885FGFR2 168/4885FPR2 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.